Castle Biosciences(CSTL)
$33.99-0.43 (-1.25%)
CSTL
Castle Biosciences Revenue
$33.99
At close:-0.43 (-1.25%)
Want to see CSTL full AI Analyst Report?
Castle Biosciences (CSTL) Revenue
474 Followers
Castle Biosciences Revenue
Castle Biosciences had a revenue of 102.89M in the quarter ending Sep 30, 2026, with -0.63%. This bring the company's revenue in the last twelve months to 377.13M, Increased 5.56%. In the fiscal year ending Dec 31, 2025, Castle Biosciences had annual revenue of 344.23M with 3.66% growth.
- Revenue (ttm)
- 377.13M
- Revenue Growth
- 9.78%
- P/S Ratio
- 3.08
- Revenue/Employee
- $343,542
- Employees
- 1,002
- Market Cap
- $1.06B
Revenue Chart
Castle Biosciences Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 344.23M | 12.16M | 3.66% |
| Dec 31, 2024 | 332.07M | 112.28M | 51.09% |
| Dec 31, 2023 | 219.79M | 82.75M | 60.38% |
| Dec 31, 2022 | 137.04M | 42.95M | 45.65% |
| Dec 31, 2021 | 94.08M | 31.44M | 50.18% |
| Dec 31, 2020 | 62.65M | 10.78M | 20.79% |
| Dec 31, 2019 | 51.87M | 29.08M | 127.62% |
| Dec 31, 2018 | 22.79M | 9.03M | 65.67% |
| Dec 31, 2017 | 13.75M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.